Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MOCLOBEMIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 291 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Borsini, F; Brambilla, A; Cesana, R; Grippa, N
      Lack of interaction between flibanserin and antidepressants in inducing serotonergic syndrome in rats

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Hoskins, JM; Gross, AS; Shenfield, GM; Rivory, LP
      High-performance liquid chromatography-electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasma

      JOURNAL OF CHROMATOGRAPHY B
    3. Stein, DJ; Kasper, S; Matsunaga, H; Osser, DN; Stein, MB; Van Ameringen, M; Versiani, M; Westenberg, H; Zhang, MY
      Pharmacotherapy of social anxiety disorder: an algorithm for primary care-2001

      PRIMARY CARE PSYCHIATRY
    4. Hoskins, JM; Shenfield, GM; Gross, AS
      A modified HPLC method for rapid detection of moclobemide and its N-oxide metabolite in human urine

      JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
    5. McDaniel, WW
      Serotonin syndrome: Early management with cyproheptadine

      ANNALS OF PHARMACOTHERAPY
    6. Fleishaker, JC; Ryan, KK; Jansat, JM; Carel, BJ; Bell, DJA; Burke, MT; Azie, NE
      Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    7. Osterbaan, DB; van Balkom, AJLM; Spinhoven, P; van Dyck, R
      The placebo response in social phobia

      JOURNAL OF PSYCHOPHARMACOLOGY
    8. Carruba, MO; Cuzzolaro, M; Riva, L; Bosello, O; Liberti, S; Castra, R; Dalle Grave, R; Santonastaso, P; Garosi, J; Nisoli, E
      Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    9. Palaska, E; Aytemir, M; Uzbay, IT; Erol, D
      Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    10. Tharwani, HM; Davidson, JRT
      Symptomatic and functional assessment of social anxiety disorder in adults

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    11. Van Ameringen, M; Mancini, C
      Pharmacotherapy of social anxiety disorder at the turn of the millennium

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    12. Stage, KB; Bech, P; Kragh-Sorensen, P; Nair, NPV; Katona, C
      Differences in symptomatology and diagnostic profile in younger and elderly depressed inpatients

      JOURNAL OF AFFECTIVE DISORDERS
    13. Schneier, FR
      Treatment of social phobia with antidepressants

      JOURNAL OF CLINICAL PSYCHIATRY
    14. Humphrey, SJ; Curry, JT; Turman, CN; Stryd, RP
      Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    15. Antal, EJ; Hendershot, PE; Batts, DH; Sheu, WP; Hopkins, NK; Donaldson, KM
      Linezolid, a novel oxazolidinone antibiotic: Assessment of monoamine oxidase inhibition using presser response to oral tyramine

      JOURNAL OF CLINICAL PHARMACOLOGY
    16. Hoskins, J; Shenfield, G; Murray, M; Gross, A
      Characterization of moclobemide N-oxidation in human liver microsomes

      XENOBIOTICA
    17. Bodkin, JA; Kwon, AE
      Selegiline and other atypical monoamine oxidase inhibitors in depression

      PSYCHIATRIC ANNALS
    18. Zobel, AW; Nickel, T; Sonntag, A; Uhr, M; Holsboer, F; Ising, M
      Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study

      JOURNAL OF PSYCHIATRIC RESEARCH
    19. Yu, KS; Yim, DS; Cho, JY; Park, SS; Park, JY; Lee, KH; Jang, IJ; Yi, SY; Bae, KS; Shin, SG
      Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    20. Adikwu, MU; Holtje, HD
      Mechanistic appraisal of the charge-transfer complexes of promethazine with chloranil: A modelling approach

      CHEMICAL & PHARMACEUTICAL BULLETIN
    21. Van Ameringen, MA; Lane, RM; Walker, JR; Bowen, RC; Chokka, PR; Goldner, EM; Johnston, DG; Lavallee, YJ; Nandy, S; Pecknold, JC; Hadrava, V; Swinson, RP
      Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study

      AMERICAN JOURNAL OF PSYCHIATRY
    22. Silverstone, T
      Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial

      ACTA PSYCHIATRICA SCANDINAVICA
    23. Allgulander, C; Nilsson, B
      A prospective study of 86 new patients with social anxiety disorder

      ACTA PSYCHIATRICA SCANDINAVICA
    24. Mann, K; Pankok, J; Leissner, J; Benkert, O
      Effects of moclobemide on sexual performance and nocturnal erections in psychogenic erectile dysfunction

      PSYCHOPHARMACOLOGY
    25. Delini-Stula, A; Cameron, A; Angst, J
      Comparative efficacy of antidepressants on anxiety features in depression:A meta-analysis of double-blind studies of imipramine and moclobemide against placebo

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    26. Davidson, JRT
      Social anxiety disorder under scrutiny

      DEPRESSION AND ANXIETY
    27. Philipp, M; Tiller, JWG; Baier, D; Kohnen, R
      Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    28. Jolkkonen, J; Kauppinen, R; Nyman, L; Haapalinna, A; Sivenius, J
      MAO-B inhibition by a single dose of l-deprenyl or lazabemide does not prevent neuronal damage following focal cerebral ischaemia in rats

      PHARMACOLOGY & TOXICOLOGY
    29. Lapatto-Reiniluoto, O; Kivisto, KT; Neuvonen, PJ
      Gastric decontamination performed 5 min after the ingestion of temazepam, verapamil and moclobemide: charcoal is superior to lavage

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    30. Wesnes, KA; Garratt, C; Wickens, M; Gudgeon, A; Oliver, S
      Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    31. Walker, JR; Van Ameringen, MA; Swinson, R; Bowen, RC; Chokka, PR; Goldner, E; Johnston, DC; Lavallie, YJ; Nandy, S; Pecknold, JC; Hadrava, V; Lane, RM
      Prevention of relapse in generalized social phobia: Results of a 24-week study in responders to 20 weeks of sertraline treatment

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    32. Ballenger, JC
      Recognizing the patient with social anxiety disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    33. Davidson, JRT
      Defining an appropriate management strategy for social anxiety disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    34. Ma, XC; Wang, Y; Liu, JH; Tu, ZH
      Moclobemide-induced gynecomastia in rats

      ACTA PHARMACOLOGICA SINICA
    35. Rouillon, F; Berdeaux, G; Bisserbe, JC; Warner, B; Mesbah, M; Smadja, C; Chwalow, J
      Prevention of recurrent depressive episodes with milnacipran: consequenceson quality of life

      JOURNAL OF AFFECTIVE DISORDERS
    36. Urichuk, LJ; Allison, K; Holt, A; Greenshaw, AJ; Baker, GB
      Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-termadministration

      JOURNAL OF AFFECTIVE DISORDERS
    37. Lin, AH; Song, C; Kenis, G; Bosmans, E; De Jongh, R; Scharpe, S; Maes, M
      The in vitro immunosuppressive effects of moclobemide in healthy volunteers

      JOURNAL OF AFFECTIVE DISORDERS
    38. Eap, CB; Bender, S; Gastpar, M; Fischer, W; Haarmann, C; Powell, K; Jonzier-Perey, M; Cochard, N; Baumann, P
      Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19-and CYP3A4/5-phenotyped patients

      THERAPEUTIC DRUG MONITORING
    39. De Angelis, L; Furlan, C
      The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    40. Keck, PE; Arnold, LM
      The serotonin syndrome

      PSYCHIATRIC ANNALS
    41. Bonnet, U; Leniger, T; Wiemann, M
      Moclobemide reduces intracellular pH and neuronal activity of CA3 neuronesin guinea-pig hippocampal slices - implication for its neuroprotective properties

      NEUROPHARMACOLOGY
    42. Hegerl, U; Moller, HJ
      Pharmacotherapy of depression in oldage

      NERVENARZT
    43. Mason, PJ; Morris, VA; Balcezak, TJ
      Serotonin syndrome - Presentation of 2 cases and review of the literature

      MEDICINE
    44. Maki, Y; Inoue, T; Izumi, T; Muraki, I; Ito, K; Kitaichi, Y; Li, XB; Koyama, T
      Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    45. Sareen, J; Stein, M
      A review of the epidemiology and approaches to the treatment of social anxiety disorder

      DRUGS
    46. Cotterchio, M; Kreiger, N; Darlington, G; Steingart, A
      Antidepressant medication use and breast cancer risk

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    47. Kristoffersen, L; Bugge, A; Lundanes, E; Slordal, L
      Simultaneous determination of citalopram, fluoxetine, paroxetine and theirmetabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection

      JOURNAL OF CHROMATOGRAPHY B
    48. FitzSimmons, CR; Metha, S
      Serotonin syndrome caused by overdose with paroxetine and moclobemide

      JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    49. Prakash, A; Foster, XH
      Paroxetine - A review of its use in social anxiety disorder

      CNS DRUGS
    50. Van Ameringen, M; Mancini, C; Oakman, JM; Farvolden, P
      Selective serotonin reuptake inhibitors in the treatment of social phobia - The emerging gold standard

      CNS DRUGS
    51. Stevinson, C; Ernst, E
      Safety of hypericum in patients with depression - A comparison with conventional antidepressants

      CNS DRUGS
    52. Tseng, AL; Foisy, MM
      Significant interactions with new antiretrovirals and psychotropic drugs

      ANNALS OF PHARMACOTHERAPY
    53. Wouters, J; Moureau, F; Evrard, G; Koenig, JJ; Jegham, S; George, P; Durant, F
      A reversible monoamine oxidase A inhibitor, befloxatone: Structural approach of its mechanism of action

      BIOORGANIC & MEDICINAL CHEMISTRY
    54. Mackay, FR; Dunn, NR; Martin, RM; Pearce, GL; Freemantle, SN; Mann, RD
      Newer antidepressants: a comparison of tolerability in general practice

      BRITISH JOURNAL OF GENERAL PRACTICE
    55. Montgomery, SA
      Social phobia: diagnosis, severity and implications for treatment

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    56. Tiller, JWG; Bouwer, C; Behnke, K
      Moclobemide and fluoxetine for panic disorder

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    57. Kruger, MB; Dahl, AA
      The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    58. Montgomery, SA
      The failure of placebo-controlled studies

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    59. Calabrese, JR; Rapport, DJ; Kimmel, SE; Shelton, MD
      Controlled trials in bipolar I depression: focus on switch rates and efficacy

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    60. Rouillon, F
      Anxiety with depression: a treatment need

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    61. Westenberg, HGM
      Facing the challenge of social anxiety disorder

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    62. Safren, SA; Heimberg, RG; Horner, KJ; Juster, HR; Schneier, FR; Liebowitz, MR
      Factor structure of social fears: The Liebowitz Social Anxiety Scale

      JOURNAL OF ANXIETY DISORDERS
    63. Gasser, R; Funk, C; Matzinger, P; Klemisch, W; Viger-Chougnet, A
      Use of transgenic cell lines in mechanistic studies of drug metabolism

      TOXICOLOGY IN VITRO
    64. Rogde, S; Hilberg, T; Teige, B
      Fatal combined intoxication with new antidepressants. Human cases and an experimental study of postmortem moclobemide redistribution

      FORENSIC SCIENCE INTERNATIONAL
    65. van Haarst, AD; van Gerven, JMA; Cohen, AF; De Smet, M; Sterrett, A; Birk, KL; Fisher, AL; De Puy, ME; Goldberg, MR; Musson, DG
      The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    66. Baker, GB; Urichuk, LJ; McKenna, KF; Kennedy, SH
      Metabolism of monoamine oxidase inhibitors

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    67. Sogaard, J; Lane, R; Latimer, P; Behnke, K; Christiansen, PE; Nielsen, B; Ravindran, AV; Reesal, RT; Goodwin, DP
      A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression

      JOURNAL OF PSYCHOPHARMACOLOGY
    68. Gillman, PK
      The serotonin syndrome and its treatment

      JOURNAL OF PSYCHOPHARMACOLOGY
    69. Silver, H; Aharon, N; Hausfater, N; Jahjah, N
      The effect of augmentation with moclobemide on symptoms of schizophrenia

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    70. Stein, DJ; Berk, M; Els, C; Emsley, RA; Gittelson, L; Wilson, D; Oakes, R; Hunter, B
      A double-blind placebo-controlled trial of paroxetine in the management ofsocial phobia (social anxiety disorder) in South Africa

      SOUTH AFRICAN MEDICAL JOURNAL
    71. Politi, E; Balduzzi, C; Bussi, R; Bellodi, L
      Artificial neural networks: a study in clinical psychopharmacology

      PSYCHIATRY RESEARCH
    72. Pollack, MH
      Social anxiety disorder: Designing a pharmacologic treatment strategy

      JOURNAL OF CLINICAL PSYCHIATRY
    73. Liebowitz, MR
      Update on the diagnosis and treatment of social anxiety disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    74. Kaltenbach, ML; Vistelle, R; Hoizey, G; Lamiable, D; Zbierski, L
      Effect of acute ethanol administration on toloxatone pharmacokinetics in rabbits

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    75. Montastruc, JL; Bagheri, H; Lapeyre-Mestre, M; Senard, JM
      Pharmacovigilance and pharmacoepidemiology: principles, definition, methods and current trends in neurology.

      REVUE NEUROLOGIQUE
    76. Heimberg, RG; Horner, KJ; Juster, HR; Safren, SA; Brown, EJ; Schneier, FR; Liebowitz, MR
      Psychometric properties of the Liebowitz Social Anxiety Scale

      PSYCHOLOGICAL MEDICINE
    77. Connor, KM; Davidson, JRT; Sutherland, S; Weisler, R
      Social phobia: Issues in assessment and management

      EPILEPSIA
    78. Bergqvist, PBF; Bouchard, C; Blier, P
      Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder

      BIOLOGICAL PSYCHIATRY
    79. George, T; Theodoros, MT; Chiu, E; Krapivensky, N; Hokin, A; Tiller, JWG
      An open study of sertraline in patients with major depression who failed to respond to moclobemide

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    80. Stein, MB; Fyer, AJ; Davidson, JRT; Pollack, MH; Wiita, B
      Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study

      AMERICAN JOURNAL OF PSYCHIATRY
    81. Ravindran, AV; Anisman, H; Merali, Z; Charbonneau, Y; Telner, J; Bialik, RJ; Wiens, A; Ellis, J; Griffiths, J
      Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments

      AMERICAN JOURNAL OF PSYCHIATRY
    82. Bruce, TJ; Saeed, SA
      Social anxiety disorder: A common, underrecognized mental disorder

      AMERICAN FAMILY PHYSICIAN
    83. VOLZ HP; GLEITER CH
      MONOAMINE-OXIDASE INHIBITORS - A PERSPECTIVE ON THEIR USE IN THE ELDERLY

      Drugs & aging
    84. Krause, KH; Krause, J; Magyarosy, I; Ernst, E; Pongratz, D
      Fibromyalgia syndrome and attention deficit hyperactivity disorder: Is there a comorbidity and are there consequences for the therapy of fibromyalgiasyndrome?

      JOURNAL OF MUSCULOSKELETAL PAIN
    85. EROGLU L; GUVEN O
      THE EFFECTS OF MOCLOBEMIDE ON THE YOHIMBINE-INDUCED ANXIOGENIC ACTIONIN THE ELEVATED PLUS-MAZE

      Pharmacological research
    86. AGUNDEZ JAG; GALLARDO L; MARTINEZ C; GERVASINI G; BENITEZ J
      MODULATION OF CYP1A2 ENZYME-ACTIVITY BY INDOLEAMINES - INHIBITION BY SEROTONIN AND TRYPTAMINE

      Pharmacogenetics
    87. Bruhwyler, J; Liegeois, JF; Gerardy, J; Damas, J; Chleide, E; Lejeune, C; Decamp, E; de Tullio, P; Delarge, J; Dresse, A; Geczy, J
      Comparative study of pirlindole, a selective RIMA, and its two enantiomersusing biochemical and behavioural techniques

      BEHAVIOURAL PHARMACOLOGY
    88. MUSSHOFF F; VARCHMINSCHULTHEISS K; MADEA B
      SUICIDE WITH MOCLOBEMIDE AND PERAZINE

      International journal of legal medicine
    89. BAIER D
      PARTICULAR ASPECTS OF ADVERSE EVENT ASSESSMENT IN POST MARKETING SURVEILLANCE

      European psychiatry
    90. Adikwu, MU; Ofokansi, KC; Attama, AA
      Thermodynamic studies of the charge-transfer interactions of chloranilic acid with moclobemide and promethazine hydrochloride

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    91. TURKCAPAR MH; ORSEL S; ISCAN EN; AKDEMIR A; KILIC EZ; OZBAY MH
      MOCLOBEMIDE AND SERTRALINE IN THE TREATMENT OF MELANCHOLIC AND NONMELANCHOLIC MAJOR DEPRESSION - A COMPARATIVE-STUDY

      Human psychopharmacology
    92. HAMPEL H; BERGER C; BUCH K; MOLLER HJ
      A REVIEW OF THE REVERSIBLE MAO-A INHIBITOR MOCLOBEMIDE IN GERIATRIC-PATIENTS

      Human psychopharmacology
    93. Buist, A; Dennerstein, L; Maguire, KP; Norman, TR
      Plasma and human milk concentrations of moclobemide in nursing mothers

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    94. GILLMAN PK
      SEROTONIN SYNDROME - HISTORY AND RISK

      Fundamental and clinical pharmacology
    95. BOERNER RJ; MOLLER HJ
      DIFFERENTIAL THERAPEUTIC STRATEGIES FOR P ATIENTS WITH SOCIAL PHOBIA

      Nervenheilkunde
    96. KORPELAINEN JT; HILTUNEN P; MYLLYLA VV
      MOCLOBEMIDE-INDUCED HYPERSEXUALITY IN PATIENTS WITH STROKE AND PARKINSONS-DISEASE

      Clinical neuropharmacology
    97. STERNIC N; KACAR A; FILIPOVIC S; SVETEL M; KOSTIC VS
      THE THERAPEUTIC EFFECT OF MOCLOBEMIDE, A REVERSIBLE SELECTIVE MONOAMINE-OXIDASE A INHIBITOR, IN PARKINSONS-DISEASE

      Clinical neuropharmacology
    98. BITSIOS P; LANGLEY RW; TAVERNOR S; PYYKKO K; SCHEININ M; SZABADI E; BRADSHAW CM
      COMPARISON OF THE EFFECTS OF MOCLOBEMIDE AND SELEGILINE ON TYRAMINE-EVOKED MYDRIASIS IN MAN

      British journal of clinical pharmacology
    99. GARERI P; STILO G; BEVACQUA I; MATTACE R; FERRERI G; DESARRO G
      ANTIDEPRESSANT DRUGS IN THE ELDERLY

      General pharmacology
    100. SCHREIBER S; GETSLEV V; WEIZMAN A; PICK CG
      THE ANTINOCICEPTIVE EFFECT OF MOCLOBEMIDE IN MICE IS MEDIATED BY NORADRENERGIC PATHWAYS

      Neuroscience letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 05:26:14